The effect of thalidomide and 2 analogs on collagen induced arthritis.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Rheumatology

• Publication date

  1998-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 9598899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel angiogenesis inhibitor suppresses rat adjuvant arthritis.

  1995cited by this paper
• Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).

  1995cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.

  1994cited by this paper
• Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

  1994cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients.

  1994cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

  1993cited by this paper
• Thalidomide for the treatment of chronic graft-versus-host disease.

  1992cited by this paper
• Effects of tumor necrosis factor alpha (TNF-alpha) on collagen arthritis.

  1992cited by this paper
• Angiogenesis inhibition suppresses collagen arthritis

  1992cited by this paper
• Thalidomide in Human Immunodeficiency Virus (HIV) Patients

  1992cited by this paper
• Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

  1992cited by this paper
• The vascular endothelial growth factor family of polypeptides

  1991cited by this paper
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

  1991cited by this paper
• Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.

  1991cited by this paper
• Vascular permeability factor: A unique regulator of blood vessel function

  1991cited by this paper
• Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

  1990cited by this paper
• Treatment of refractory rheumatoid arthritis--the thalidomide experience.

  1989cited by this paper
• The effect of thalidomide on experimental autoimmune myasthenia gravis.

  1989cited by this paper
• A short history of thalidomide embryopathy.

  1988cited by this paper
• ENHANCEMENT OF ANTIBODY RESPONSE AND DELAYED‐TYPE HYPERSENSITIVITY BY THALIDOMIDE IN MICE

  1988cited by this paper
• Angiogenic factors.

  1987cited by this paper
• Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.

  1981cited by this paper
• STUDY WITH NINE THALIDOMIDE DERIVATIVES IN THE LEPRA REACTION

  1978cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper
• Thalidomide in the treatment of lepra reactions

  1965cited by this paper
• EVALUATION OF THE TERATOGENICITY OF DRUGS.

  1964cited by this paper

• Avascular Necrosis of Humeral Head after Thalidomide Use: A Report of Two Cases

  2018cites this paper
• An open label clinical trial of thalidomide in NSAIDs refractory ankylosing spondylitis

  2018cites this paper
• Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

  2017cites this paper
• Anti-angiogenic therapy (bevacizumab) in the management of oral lichen planus.

  2016cites this paper
• Targeting Chemokines and Angiogenesis in Rheumatoid Arthritis

  2011cites this paper
• Dapsone, penicillamine, thalidomide, bucillamine, and the tetracyclines

  2011cites this paper
• Role of Angiogenesis in the Pathogenesis of Arthritis: Potential Therapeutic Applications

  2010cites this paper
• Ameliorative Effect of Adalimumab on Experimentally Induced Acute Pancreatitis in Rats

  2010cites this paper
• THALIDOMIDE SUPPRESSES SCLEROSING ENCAPSULATING PERITONITIS IN A RAT EXPERIMENTAL MODEL

  2009cites this paper
• On the effect of thalidomide on Mycobacterium avium subspecies paratuberculosis in culture.

  2009cites this paper
• Angiogenesis in rheumatoid arthritis

  2009cites this paper
• CHAPTER 8I – Endothelial Cells and Angiogenesis

  2009cites this paper
• The thalidomide analog 3-phthalimido-3-(3,4-dimethoxyphenyl)-propanoic acid improves the biliary cirrhosis in the rat.

  2009cites this paper
• Angiogenesis and its targeting in rheumatoid arthritis.

  2009cites this paper
• Disease modifying and antiangiogenic activity of 2-Methoxyestradiol in a murine model of rheumatoid arthritis

  2009cites this paper
• Angiogenesis inhibitors for the treatment of chronic autoimmune inflammatory arthritis.

  2009cites this paper
• Targeting Angiogenesis in Rheumatoid Arthritis.

  2008cites this paper
• EFFECT OF THALIDOMIDE ON SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA

  2008cites this paper
• Angiogenesis and chronic inflammation: cause or consequence?

  2007cites this paper
• EFFECTS OF THALIDOMIDE IN A MOUSE MODEL OF CERULEIN-INDUCED ACUTE PANCREATITIS

  2007cites this paper
• Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis

  2007cites this paper
• Preventive and therapeutic anti-inflammatory effects of systemic and topical thalidomide on endotoxin-induced uveitis in rats.

  2007cites this paper
• New antiangiogenic strategies for the treatment of proliferative synovitis

  2005cites this paper
• THALIDOMIDE TREATMENT REDUCES COLON INJURY INDUCED BY EXPERIMENTAL COLITIS

  2005cites this paper
• Immunotherapy of rheumatoid arthritis: past, present and future.

  2005cites this paper
• Drugs to suppress cough

  2005cites this paper
• Original Research Papers Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis

  2004cites this paper
• Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats

  2004cites this paper
• The effects of thalidomide on the stimulation of NF-kappaB activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line.

  2004cites this paper
• Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat.

  2004cites this paper
• Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis

  2004cites this paper
• Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response1

  2003cites this paper
• Thalidomide ameliorates carbon tetrachloride induced cirrhosis in the rat

  2003cites this paper
• Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis 1

  2003cites this paper
• Effect of thalidomide and rosiglitazone on the prevention of diabetic retinopathy in streptozotocin-induced diabetic rats

  2003cites this paper
• The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.

  2003cites this paper
• Important Role in Immune Response Cu/Zn Superoxide Dismutase Plays

  2003cites this paper
• Thalidomide and its derivatives: emerging from the wilderness

  2003cites this paper
• K / BxN Model of Rheumatoid Arthritis VEGF-RII , Suppresses Joint Destruction in Factor Receptor I ( VEGF-RI ) , but not Blockade of Vascular Endothelial Growth

  2003cites this paper
• The therapeutic potential of TNF-α blockade in rheumatoid arthritis

  2003cites this paper
• Thalidomide: an old wine in new bottle.

  2003cites this paper
• Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis

  2003cites this paper
• Thalidomide : An old wine in new bottle MB

  2003cites this paper
• Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response

  2003cites this paper
• The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis.

  2002cites this paper
• Angiogenesis in rheumatoid arthritis

  2002cites this paper
• The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis

  2002cites this paper
• Immunological effects of thalidomide and its chemical and functional analogs.

  2002cites this paper
• One-year open-label trial of thalidomide in ankylosing spondylitis.

  2002cites this paper
• Effect of direct angiogenesis inhibition in rheumatoid arthritis using a soluble vascular endothelial growth factor receptor 1 chimeric protein.

  2002cites this paper
• Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity*

  2001cites this paper
• Effects of thalidomide and 3‐phthalimido‐3‐(3,4‐dimethoxyphenyl)‐propanamide on bile duct obstruction‐induced cirrhosis in the rat

  2001cites this paper
• Update on synovitis

  2001cites this paper
• Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma

  2001cites this paper
• Immunotherapeutic and antitumour potential of thalidomide analogues

  2001cites this paper
• Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.

  2001cites this paper
• Thalidomide impairment of trinitrobenzene sulphonic acid‐induced colitis in the rat–role of endothelial cell‐leukocyte interaction

  2001cites this paper
• Tumour necrosis factor-alpha: the role of this multifunctional cytokine in asthma.

  2001cites this paper
• TARGETING TUMOR NECROSIS

  2001cites this paper
• Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.

  2001cites this paper
• Thalidomide: a comeback?

  2000cites this paper
• Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.

  2000cites this paper
• Thalidomide: a re-look.

  2000cites this paper
• Thalidomide : le retour ?

  2000cites this paper
• The role of angiogenesis in rheumatoid arthritis: recent developments

  2000cites this paper
• Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis

  2000cites this paper
• The re-emergence of thalidomide: results of a scientific conference.

  2000cites this paper
• Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus

  2000cites this paper
• Angiogenèse : mécanismes généraux et implications au cours de la polyarthrite rhumatoïde * Ce travail a été financé par la Société française de rhumatologie, la Fondation pour la recherche médicale et l'Association de recherche sur la polyarthrite.

  2000cites this paper
• Small molecule inhibitors of tumor-promoted angiogenesis, including protein tyrosine kinase inhibitors.

  1999cites this paper
• Thalidomide as an emerging immunotherapeutic agent.

  1999cites this paper
• New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders

  1999cites this paper
• Desórdenes inmunológicos y el resurgimiento de la talidomida. Nuevas aplicaciones clínicas

  1999cites this paper
• Thalidomide analogue CC1069 inhibits development of rat adjuvant arthritis

  1999cites this paper
• Mycoplasma fermentans—Induced Inflammatory Response of Astrocytes: Selective Modulation by Aminoguanidine, Thalidomide, Pentoxifylline and IL-10

  1999cites this paper